Jane Street Group, LLC Corbus Pharmaceuticals Holdings, Inc. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 16, 2021	SELL	$1.01 - $1.82 $1,111 - $2,002	-1,100 Reduced 8.94%	11,200 $11,000
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $59,769 - $95,030	-43,000 Reduced 77.76%	12,300 $23,000
Q1 2021 May 18, 2021	BUY	$1.27 - $3.42 $45,212 - $121,752	35,600 Added 180.71%	55,300 $109,000
Q4 2020 Feb 17, 2021	SELL	$0.94 - $1.89 $331,914 - $667,359	-353,100 Reduced 94.72%	19,700 $25,000
Q3 2020 Nov 17, 2020	BUY	$1.5 - $9.38 $535,050 - $3.35 Million	356,700 Added 2215.53%	372,800 $671,000
Q2 2020 Aug 17, 2020	BUY	$4.79 - $8.39 $77,119 - $135,079	16,100 New	16,100 $135,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.62B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.